Last update:

Endocrinology news

Being obese can make you more likely to be unemployed

The effect of obesity on unemployment is more than twice as large as previously thought, finds a UK Biobank study of genetic evidence.

Semaglutide and other GLP-1 drugs not linked to risk of degenerative eye disease in adults with type 2 diabetes

An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of medication that mimics the GLP-1 hormone—to lower blood sugar and support weight loss. Some research ...

Rise of GLP-1s raises long-term affordability questions

As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new Northwestern University study that analyzed national trends in GLP-1 use and spending between 2017 and 2022. ...

What's driving the obesity pandemic?

New research presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico, (15–17 July) asks what is driving the obesity pandemic.

Muscles matter for diabetes risk, new study finds

A major new international study led by Curtin University has found diabetes risk is about more than body weight or obesity, revealing that muscle health also likely plays a major role in whether people develop the condition.

Weight‑loss jabs may create a new kind of yo‑yo dieting

For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped under the label GLP-1 medicines because they mimic hormones released after ...

7 things to know about Medicare's new GLP-1 coverage

For decades, it's been against the law for Medicare to pay for weight-loss medication. But that changed on July 1, with the launch of a new program called Bridge. It gives some people over 65, or who have Medicare for other ...

Hearing loss in diabetes patients a 'hidden epidemic'

Researchers are calling for hearing tests to become a standard part of diabetes care and for hearing loss to be recognized as a significant complication of the condition. Dr. Mehwish Nisar from UQ's School of Public Health ...

Diabetes linked to worse long COVID outcomes

People with diabetes who have had COVID-19 tend to recover more slowly, experience more long COVID complications, have a poorer quality of life, and require closer and more prolonged monitoring by medical teams. This was ...

New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks

A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12% reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature ...

Low testosterone linked to cancer risk in men

New research shows men with very low testosterone levels are at higher risk of both fatal and nonfatal cancer later in life. But while the research found men with low testosterone were 18% more likely to die of cancer years ...